Familial aggregation of breast cancer with early onset lung cancer

Genetic Epidemiology

Volumn 17, Issue 4, 1999, Pages 274-284

  Schwartz, Ann G ^a,c   Siegfried, Jill M ^b   Weiss, Linda ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Familial aggregation; Genetics; Lung cancer; Smoking

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CHILD; COMORBIDITY; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENETIC RISK; HUMAN; INFANT; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE OF ONSET; BREAST NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; FAMILY HEALTH; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LUNG NEOPLASMS; MALE; SMOKING;

EID: 0032755751     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2272(199911)17:4<274::AID-GEPI3>3.0.CO;2-A     Document Type: Article

References (51)

1. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR Laughlin R, Nemoto T, Michalek AM, Harrington A, Ford TD, Shields PG. 1995. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res 55:3483-3485.
2. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR Michalek AM, Laughlin R, Nemoto T, Gillenwater KA, Harrington AM, Shields PG. 1996. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 276:1494-1501.
3. Anderson KE, Woo C, Olson JE, Sellers TA, Zheng W, Kushi LH, Folsom AR. 1997. Association of family history of cervical, ovarian, and uterine cancer with histologic categories of lung cancer: the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 6:401-405.
4. Bailey LR, Roodi N, Dupont WD, Parl FF. 1998. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res 58:5038-5041.
5. Baron JA, Newcomb PA, Longnecker MP, Mittendorf R, Storer BE, Clapp RW, Bogdan G, Yuen J. 1996. Cigarette smoking and breast cancer. Cancer Epidemiol Biomarkers Prev 5:399-403.
6. Bondy ML, Strom SS, Colopy MW, Brown BW, Strong LC. 1994. Accuracy of family history of cancer obtained through interviews with relatives of patients with childhood sarcoma. J Clin Epidemiol 47:89-96.
7. Cagle PT, Mody DR, Schwartz MR. 1990. Estrogen and progesterone receptors in bronchogenic carcinoma. Cancer Res 50:6632-6635.
8. Caltagirone S, Ranelletti FO, Rinelli A, Maggiano N, Colasante A, Musiani P, Aiello FB, Piantelli M. 1997. Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small cell lung cancer. Am J Respir Cell Mol Biol 17:51-59.
9. Canver CC, Memoli VA, Vanderveer PL, Dingivan CA, Mentzer RM. 1994. Sex hormone receptors in non-small cell lung cancer in human beings. J Thorac Cardiovasc Surg 108:153-157.
10. Cascorbi I, Brockmuller J, Mrozikiewicz PM, Bauer S, Loddenkemper R, Roots I. 1996. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. Cancer Res 56:3961-3966.
11. Cooper JA, Rohan TE, Cant EL, Horsfall DJ, Tilley WD. 1989. Risk factors for breast cancer by oestrogen receptor status: a population-based case-control study. Br J Cancer 59:119-125.
12. Cutler SJ, Young JL, editors. 1975. Third National Cancer Survey: Incidence Data. DHEW Publication No. 75-787. National Cancer Institute Monograph 41.
13. Daniell HW. 1984. Estrogen receptors, breast cancer, and smoking. N Engl J Med 302:1478.
14. Gloeckler Ries LA, Hankey BF, Edwards BK, editors. 1990. Cancer Statistics Review, 1973-1987. Bethesda, MD: National Cancer Institute. NIH Publication No. 90-2789.
15. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. 1994. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600-1608.
16. Gray WG, Biswas EE, Bashierlahi N, Biswas SB. 1994. A low-affinity estrogen-binding site in pregnant rat uteri: analysis and partial purification. Proc Natl Acad Sci USA 91:11502-11506.
17. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, Sutter TR. 1996. 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci USA 93:9776-9781.
18. Ishibe N, Hankinson SE, Colditz GA, Spiegelman D, Willett WC, Speizer FE, Kelsey KT, Hunter DJ. 1998. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurse's Health Study. Cancer Res 58:667-671.
19. Kaiser U, Hofmann J, Schilli M, Wegman B, Klotz U, Wedel S, Virmani AK, Wollmer E, Branscheid D, Gadzar AF, Havemann K. 1996. Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer. Int J Cancer 67:357-364.
20. Kawajiri K, Natachi K, Luai K, Yoshi A, Shinodo N, Watanabe J. 1990. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Lett 263:131-133.
21. Kosary CL, Ries LAG, Miller BA, Hankey BF, Harras A, Edwards BK, editors. 1995. SEER Cancer Statistics Review, 1973-1992: Tables and Graphs. Bethesda, MD: National Cancer Institute. NIH Publication No. 96-2789.
22. Li D, Wang M, Dhingra K, Hittelman WN. 1996. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res 56:287-293.
23. Love RR, Evans AM, Josten DM. 1985. The accuracy of patient reports of a family history of cancer. J Chronic Dis 38:289-293.
24. Malkin D, Li FP, Strong LC, Fraumeni JF, Jr., Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff JZ, Tainsky MA, Friend SH. 1990. Germline p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238.
25. Martinez C, Agundez JA, Olivera M, Martin R, Ladero JM, Benitez J. 1995. Lung cancer and mutations at the polymorphic NAT2 gene locus. Pharmacogenetics 5:-207-214.
26. Martucci CP, Fishman J. 1993. P450 enzymes of estrogen metabolism. Pharm Ther 57:237-257.
27. McWilliams JE, Sanderson BJ, Harris EL, Richert-Boe KE, Henner WD. 1995. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomark Prev 4:589-594.
28. Morabia A, Bernstrin M, Rutz J, Heritier S, Diebold Berger S, Borisch B. 1998. Relation of smoking to breast cancer by estrogen receptor status. Int J Cancer 75:339-342.
29. Nebert DW, McKinnon RA, Puga A. 1996. Human drug metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol 15:273-280.
30. Ollayos CW, Riordan GP, Rushkin JM. 1994. Estrogen receptor detection in paraffin sections of adenocarcinoma of the colon, pancreas, and lung. Arch Pathol Lab Med 118:630-632.
31. Ooi WL, Elston RC, Chen VW, BaileyWilson JE, Rothschild H. 1986. Increased familial risk for lung cancer. J Natl Cancer Inst 76:217-222.
32. Oyama T, Kawamoto T, Mizoue T, Yasumoto K, Kodama Y, Mitsudomi T. 1997. N-acetylation polymorphism in patients with lung cancer and its association with p53 gene mutation. Anticancer Res 17:577-582.
33. Palmer J, Rosenberg L. 1993. Cigarette smoking and the risk of breast cancer. Epidemiol Rev 15:145-156.
34. Petrakis NL, Gruenke LD, Beelen TC, Castagnoli N Jr, Craig JC. 1978. Nicotine in breast fluid of nonlactating women. Science 199:303-304.
35. Petrakis NL, Maack CA, Lee RE, Lyon M. 1980. Mutagenic activity in nipple aspirates of human breast fluid. Cancer Res 40:188-189.
36. Rebbeck TR. 1997. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomark Prev 6:733-743.
37. SAS Institute Inc. 1997. SAS/STAT software: changes and enhancements through release 6.12. Cary, NC: SAS Institute Inc.
38. Scambi G. Ranelletti FO, Panici PB, Piantelli M, De Vincenzo R, Ferradina G, Bonanno G, Capelli A, Moncuso S. 1993. Quercetin induces type II estrogen-binding sites in estrogen-receptor negative (MDA-MB231) and estrogen-receptor positive (MCF-7) human breast-cancer cell lines. Int J Cancer 54:462-466.
39. Schwartz AG, Yang P, Swanson GM. 1996. Familial risk of lung cancer among nonsmokers and their relatives. Am J Epidemiol 144:554-562.
40. Schwartz AG, Rothrock M, Yang P, Swanson GM. 1999. Increased cancer risk among relatives of nonsmoking lung cancer cases. Genetic Epidemiol 17:1-15.
41. Schwartz AG, Lassige D, Gillen-Caralli D, Shriver M, Weiss L. 1999. CYP1B1 and risk of early onset and non-cigarette smoking associated lung cancer. Proc Am Assoc Cancer Res 40:90.
42. Sellers TA, Ooi WL, Elston RC, Chen VW, Bailey Wilson JE, Rothschild H. 1987. Increased familial risk for nonlung cancer among relatives of lung cancer patients. Am J Epidemiol 126:237-246.
43. Sellers TA, Bailey-Wilson JE, Elston RC, Wilson AF, Elston GZ, Ooi WL, Rothschild H. 1990. Evidence for Mendelian inheritance in the pathogenesis of lung cancer. J Natl Cancer Inst 82:1272-1279.
44. Sellers TA, Potter JD, Folsom AR. 1991. Association of incident lung cancer with family history of female reproductive cancers: the Iowa Women's Health Study. Genetic Epidemiol 8:199-208.
45. Shaw GL, Falk RT, Pickle LW, Mason TJ, Buffler PA. 1991. Lung cancer risk associated with cancer in relatives. J Clin Epidemiol 44:429-437.
46. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, Sutter TR. 1996. Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Res 56:2979-2984.
47. Struewing JP, Hartage P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA. 1997. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New Engl J Med 336:1401-1408.
48. Sugimura H, Hamada GS, Suzuki I, Iwase T, Kiyokawa E, Kino I, Tsugane S. 1995. CYP1A1 and CYP2E1 polymorphisms and lung cancer, a case-control study in Rio de Janeiro, Brazil. Pharmacogenetics 5:S145-148.
49. Taioli E, Wynder EL. 1994. Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 84:869-870.
50. Yang P, Schwartz AG, McAllister AE, Swanson GM, Aston CE. 1999. Lung cancer risk in families of nonsmoking probands: heterogeneity by age at diagnosis. Genetic Epidemiol 17:253-273
51. Zeger SL, Liang KY. 1986. Longitudinal data analysis for discrete continuous outcomes. Biometrics 42:121-130.